|
|
|
|
|
Topics |
|
High-grade gliomas | Treatment | Targeted therapy | Avapritinib |
|
|
|
|
|
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Avapritinib |
|
|
|
|
|
Mayr
L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, Eder SK,
Weiler-Wichtl L, Marques JG, de Biagi-Junior CAO, Lo Cascio C,
Chapman O, Sridhar S, Kenkre R, Dutta A, Wang S, Wang J, Hack O,
Nascimento A, Nguyen CM, Castellani S, Rozowsky JS, Groves A,
Panditharatna E, Cruzeiro GAV, Haase RD, Tabatabai K, Madlener S,
Wadden J, Adam T, Kong S, Miclea M, Patel T, Bruckner K, Senfter
D, Lämmerer A, Supko J, Guntner AS, Palova H, Neradil J,
Stepien N, Lötsch-Gojo D, Berger W, Leiss U, Rosenmayr V,
Dorfer C, Dieckmann K, Peyrl A, Azizi AA, Baumgartner A, Slaby O,
Pokorna P, Clark LM, Cameron A, Nguyen QD, Wakimoto H, Dubois F,
Greenwald NF, Bandopadhayay P, Beroukhim R, Ligon K, Kramm C,
Bronsema A, Bailey S, Stucklin AG, Mueller S, Skrypek M, Martinez
N, Bowers DC, Jones DTW, Jones C, Jäger N, Sterba J, Müllauer
L, Haberler C, Kumar-Sinha C, Chinnaiyan A, Mody R, Chavez L,
Furtner J, Koschmann C, Gojo J, Filbin MG. |
|
|
|
|
|
|
|
|
|
|